ENTITY
Akeso Biopharma Inc

Akeso Biopharma Inc (9926 HK)

281
Analysis
Health Care • China
Akeso Inc. operates operatesa s a biotech company. The compnay develops treatments and therapies for various types of diseases. Akeso serves cutomers worldwide
more
bearish•Quantitative Analysis
•20 Oct 2024 10:05

HK Short Interest Weekly: Smic, Anta Sports, Cspc Pharma, Nci, Meituan, Tencent, Baba

We analyzed the latest HK SFC report for aggregate short position as of Oct 10th and highlight short interest changes in Smic, Anta Sports, Cspc...

Logo
626 Views
Share
•20 Oct 2024 07:30

APAC Healthcare Weekly (Oct 20)- Eisai, Daiichi Sankyo, Junshi Bioscience, Akeso, Celltrion, Neuren

This insight collates key news in APAC healthcare last week. With the earnings season beginning to unfold along with major pharma and healthcare...

Logo
498 Views
Share
bullish•Akeso Biopharma Inc
•14 Oct 2024 08:55

Akeso Biopharma Placement - The Placing Price Is Not Cheap Despite Positive Business Progress

​Akeso delivers impressive HARMONi-2 data, which greatly increases the possibility of positive OS. But the market cap already partially reflects...

Logo
727 Views
Share
bullish•Tokyo Metro
•14 Oct 2024 08:44

ECM Weekly (14th Oct 2024) - Tokyo Metro, Rigaku, Hyundai, China Res, Swiggy, USS, Akeso, Shiyue

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
663 Views
Share
•13 Oct 2024 09:54

China Healthcare Weekly (Oct.13)-Genor to Acquire Edding, RemeGen's Bleak Outlook, Zai Lab's Trouble

Genor/Edding are merging through a reverse takeover, but valuation is unsatisfactory. Remegen is negative example among China Biotech.Weak...

Logo
715 Views
Share
x